GIP receptor engagement increases noticeably
Those early results have sparked widespread attention on social media, especially among influencers and wellness communities eager for the next semaglutide. But the science, and the approval process, arent finished yet
Hims and Hers offer compounded GLP-1 medications through licensed, FDA-registered US pharmacies, but the medications themselves are not FDA approved and availability can vary by state
The progression of LN to ESKD is influenced by various factors, including the initial nephron number (determined at birth), episodes of nephron loss (during LN flare), and the rate of nephron loss beyond physiological aging (ongoing inflammation due to LN) or in some cases concomitant uncontrolled diabetes mellitus, and/or hypertension ( Effective management of LN during pregnancy is pivotal to minimizing maternal and fetal risks
What other factors influence GLP-1 effectiveness
Nausea, vomiting, diarrhea, and constipation are frequently reported, especially during initial dose escalation phases
